Form 4 holding
Chief Innovation/Tech Officer
Aquestive Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 984,476
- Estimated value
- $4,804,243
- Report date
- 15 Mar 2024
- Price
- $4.88
- Ownership
- Direct
Alexander Mark Schobel - Chief Innovation/Tech Officer at Aquestive Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Innovation/Tech Officer
- Issuer ticker
- AQST on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Alexander Mark Schobel since 18 Aug 2025
Reported holdings for Alexander Mark Schobel in Aquestive Therapeutics, Inc.
Form 4 holding
Chief Innovation/Tech Officer
Aquestive Therapeutics, Inc.
- Security class
- Performance Stock Units
- Shares / value
- 50,000
- Estimated value
- Report date
- 09 Aug 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Innovation/Tech Officer
Aquestive Therapeutics, Inc.
- Security class
- Non-Qualified Stock Option (right to buy)
- Shares / value
- 41,250
- Estimated value
- Report date
- 07 Mar 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Alexander Mark Schobel in Aquestive Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.